Related Experiment Video
Updated: Jun 18, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Measles virus: evidence for association with lung cancer
Netta Sion-Vardy1, Irena Lasarov, Bertha Delgado
1Department of Pathology, Soroka University Medical Center, Beer Sheva, Israel. nsv@bgu.ac.il
Abstract:
In recent years the frequency of nonsmokers among lung cancer patients has increased to 10% to 15%. The measles virus has rarely been evoked as an etiological agent in malignant tumors and its role in carcinogenesis remains doubtful. It has been suggested that measles virus phosphoprotein may inhibit ubiquitination of Pirh2, which has been reported to be overexpressed in lung carcinoma and is responsible for degrading the cell cycle regulator p53. The authors conducted a clinicopathological study of newly diagnosed patients with non-small cell lung carcinoma of all stages seen in a 10-year period. Immunohistochemical studies for measles virus antigens, p53, and Pirh2 were performed using the avidin-biotin peroxidase complex. The authors found expression of measles virus antigens in 54 of 65 cases of non-small cell lung carcinoma. This finding is associated with the older age of the patients and with expression of Pirh2. The presence of Pirh2 itself was associated with improved survival.
Insights
Measles virus antigens were found in most non-small cell lung cancer cases. Pirh2 expression, linked to measles virus, correlated with better patient survival, suggesting a potential role in lung cancer progression.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Lung cancer incidence in nonsmokers is rising (10-15%).
- The role of measles virus in cancer (carcinogenesis) is largely unestablished.
- Measles virus phosphoprotein may affect Pirh2, a protein overexpressed in lung cancer that degrades p53.
Purpose of the Study:
- To investigate the association between measles virus antigens, Pirh2, p53, and clinicopathological features in non-small cell lung carcinoma (NSCLC).
Main Methods:
- Clinicopathological study of 65 newly diagnosed NSCLC patients over 10 years.
- Immunohistochemical analysis for measles virus antigens, p53, and Pirh2 using avidin-biotin peroxidase complex.
Main Results:
- Measles virus antigens detected in 54 of 65 (83%) NSCLC cases.
- Measles virus antigen expression was associated with older patient age and Pirh2 expression.
- Pirh2 expression was independently associated with improved patient survival.
Conclusions:
- Measles virus antigens are frequently present in NSCLC.
- Pirh2 expression, potentially influenced by measles virus, may be a favorable prognostic marker in NSCLC.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Respiratory Syncytial Virus Disease
Mechanisms of Retrovirus-induced Cancers
